A Maximum Likelihood Estimator of a Markov Model for Disease Activity in Crohn’s Disease and Ulcerative Colitis for Annually Aggregated Partial Observations

Medical Decision Making - United States
doi 10.1177/0272989x09336141
Full Text
Abstract

Available in full text

Categories
Health Policy
Date
Authors
Publisher

SAGE Publications

Related search

Differential Intestinal Mucosa Transcriptomic Biomarkers for Crohn’s Disease and Ulcerative Colitis

Journal of Immunology Research
MedicineAllergyImmunology
2018English

Autoimmune Thyroid Diseases Concomitant With Crohn’s Disease and Ulcerative Colitis

Journal of Thyroid Disorders & Therapy
2014English

Correlation of Biomarker Expression in Colonic Mucosa With Disease Phenotype in Crohn’s Disease and Ulcerative Colitis

Digestive Diseases and Sciences
PhysiologyGastroenterology
2015English

Abatacept for Crohn's Disease and Ulcerative Colitis

Gastroenterology
HepatologyGastroenterology
2012English

Activity-Based Costing and Budget Analysis of Vedolizumab Versus Conventional Treatments in Ulcerative Colitis and Crohn’s Disease

Global and Regional Health Technology Assessment
Health Policy
2017English

A Targeted Maximum Likelihood Estimator for Two-Stage Designs

International Journal of Biostatistics
MedicineUncertaintyStatisticsProbability
2011English

Recent Trends in the Prevalence of Crohn’s Disease and Ulcerative Colitis in a Commercially Insured US Population

Digestive Diseases and Sciences
PhysiologyGastroenterology
2012English

A Gastroenterologist’s Perspective of the Medical Management of Patients With Crohn’s Disease and Ulcerative Colitis

Canadian Journal of Gastroenterology
1996English

Crohn’s Disease and Ulcerative Colitis Are Associated With Elevated Standardized Mortality Ratios

Inflammatory Bowel Diseases
AllergyImmunologyGastroenterology
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy